A0A6P5RF57 (A0A6P5RF57_MUSCR) Mus caroli (Ryukyu mouse) (Ricefield mouse)

Mitogen-activated protein kinase 14 UniProtKBInterProInteractive Modelling

360 aa; Sequence (Fasta) ; 3 identical sequences: Peromyscus maniculatus bairdii: A0A6I9LHS5; Mus musculus: P47811; Cricetulus griseus: A0A8C2MW48

Available Structures

121 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form with bound… Heteromer
P47811; Q8CF89;
3-354
100SB4;SO4;EDO;
Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form) Heteromer
P47811; Q8CF89;
3-353
100SB4;TLA;EDO;
Structure of MAP kinase in complex with a docking peptide Heteromer
P47811; Q15750;
4-354
100.0
CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A Heteromer
P47811; Q02078;
5-354
100.0
CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS ACTIVATOR MKK3B Heteromer
O09110; P47811;
4-353
100.0
Structural basis of autoactivation of p38 alpha induced by TAB1 (Monoclinic crystal form) Heteromer
P47811; Q8CF89;
5-353
100SB4;
Crystal structure of a P38alpha T185G mutant in complex with TAB1 peptide. Heteromer
P47811; Q15750;
5-353
99.7SB4;
Crystal structure of phosphorylated p38aMAPK in complex with TAB1 Heteromer
P47811; Q15750;
5-352
100.0NI;AGS;MG;
Structure of p38alpha complex Heteromer
P47811; P49137;
6-353
100.0
Crystal structure of p38alpha in complex with a MAPK docking partner Heteromer
P47811; Q9Y6W6;
5-352
100.0
Ternary complex of P38 and MK2 with a P38 inhibitor Heteromer
P47811; P49137;
6-353
100.039G;
Crystal structure of p38alpha C162S in complex with ATPgS and CAS 2094667-81-7 (in catalytic site, …homo-2-mer4-353
99.7187B;ATP;
Crystal structure of p38 in complex with SR72monomer1-360
100.0EDO;O8Q;
A structural study of selectivity mechanisms for JNK3 and p38 alpha with indazole scaffold probing …monomer5-360
100.0BOG;WHQ;
Fragment KCL802 in complex with MAP kinase p38-alphamonomer5-359
99.71SB4;CA;DMS;LOT;
Fragment KCL_916 in complex with MAP kinase p38-alphamonomer5-359
99.71OFZ;SB4;CA;CL;SO4;
Fragment KCL_914 in complex with MAP kinase p38-alphamonomer5-359
99.71OG2;SB4;CA;CL;SO4;
Fragment KCL_804 in complex with MAP kinase p38-alphamonomer6-360
99.71SB4;CA;308;
Fragment KCL_771 in complex with MAP kinase p38-alphamonomer5-359
99.71SB4;CA;CL;OFQ;
Fragment KCL_1410 in complex with MAP kinase p38-alphamonomer5-359
99.71OG8;SB4;CA;CL;SO4;
Fragments KCL_615 and KCL_802 in complex with MAP kinase p38-alphamonomer6-359
99.71SB4;CA;LOT;LOW;SO4;
Fragment KCL_K767 in complex with MAP kinase p38-alphamonomer6-359
99.71SB4;CA;OL8;
Fragment KCL_K777 in complex with MAP kinase p38-alphamonomer6-359
99.71SB4;CA;OKZ;
Novel p38-alpha crystal lattice with highly exposed p38/TAB1 non-canonical PPI surface.monomer6-359
99.71SB4;CA;CL;
Fragment KCL615 in complex with MAP kinase p38-alphamonomer6-359
99.71SB4;CA;CL;LOW;
Fragment KCL_1337 in complex with MAP kinase p38-alphamonomer6-359
99.71SB4;CA;CL;OFW;
Fragments KCL_771 and KCL_802 in complex with MAP kinase p38-alphamonomer6-359
99.71SB4;CA;CL;OFQ;LOT;
Fragment KCL_1088 in complex with MAP kinase p38-alphamonomer6-359
99.71SB4;CA;CL;DMS;EDO;OG5;
Crystal structure of phosphorylated p38alpha MAP kinasemonomer1-354
100
Crystal structure of p38 in complex with SR68monomer5-355
100.0O8Z;EDO;
Crystal structure of p38 in complex with SR65monomer5-355
100.0O98;EDO;
Crystal structure of p38 in complex with SR69monomer5-355
100.0O8T;EDO;
Crystal structure of p38 in complex with SR43monomer5-355
100.0OU2;EDO;
Crystal structure of p38 in complex with SR63.monomer5-355
100.0O8W;EDO;
Crystal structure of p38 alpha MAPK14 in complex with VPC00628monomer4-353
1006SH;
Mutated Mus Musculus P38 Kinase (mP38)monomer4-353
100.0PGJ;
p38a bound with MCP-81monomer4-353
100.0OE5;
Dual binding mode of pyridinylimidazole to MAP kinase p38monomer5-354
99.39SB2;
Crystal structure of WT p38alphamonomer4-353
100.0MG;SB2;
Crystal structure of p38alpha C162S in complex with SB20358 and CAS 2094667-81-7 (behind catalytic …monomer5-354
99.71IIM;87B;
The third conformation of p38a MAP kinase observed in phosphorylated p38a and in solutionmonomer4-353
99.7
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL081 in complex with MAP …monomer4-352
100.0SOV;CL;MG;SO4;DMS;ACT;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14274a in complex with MAP…monomer4-352
100.0SRJ;CL;MG;SO4;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL077 in complex with MAP …monomer4-352
100.0SOJ;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14246a in complex with MAP…monomer4-352
100.0SR4;CL;SO4;DMS;MG;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14231a in complex with MAP…monomer4-352
100.0LXS;CL;MG;SO4;DMS;
Fragment N13788a in complex with MAP kinase p38-alphamonomer4-352
100.0LOK;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL093 in complex with MAP …monomer4-352
100.0SQ4;CL;MG;SO4;EDO;
Fragment N13460a in complex with MAP kinase p38-alphamonomer4-352
100.0JGG;CL;MG;SO4;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11145a in complex with MAP…monomer4-352
100.0SNJ;CL;MG;SO4;ACT;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL063 in complex with MAP …monomer4-352
100.0SO7;CL;MG;SO4;DMS;ACT;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N08078b in complex with MAP…monomer4-352
100.0SMV;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13421a in complex with MAP…monomer4-352
100.0JFS;CL;MG;SO4;
Crystal structure of p38alpha in complex with SR154monomer4-352
100.0OSZ;EDO;
Crystal structure of MAP kinase p38 alpha in complex with inhibitor SR276monomer4-352
100.0EDO;TKB;
p38a bound with SR92monomer5-353
100.0OEB;EDO;
Crystal structure of MAP kinase p38 alpha in complex with inhibitor SR159monomer4-352
100.0TK5;
THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTROMS RESOLUTIONmonomer5-353
100.0
Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1monomer5-353
99.7
Crystal structure of WT p38alphamonomer4-352
100.0SB2;MG;
MAPK14 bound with SR302monomer5-353
100.0TBK;
MAPK14 bound with SR300monomer5-353
100.0TJZ;EDO;MES;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13662a in complex with MAP…monomer5-352
100RUY;CL;SO4;MG;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13596a in complex with MAP…monomer5-352
100SSY;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N09139b in complex with MAP…monomer5-352
100.0SLV;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N05703b in complex with MAP…monomer5-352
100.0SLS;CL;SO4;DMS;MG;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment TCJ658 in complex with MAP …monomer5-352
100.0SQV;CL;MG;SO4;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment K00283c in complex with MAP…monomer5-352
100JND;CL;MG;SO4;DMS;
Fragment N13565a in complex with MAP kinase p38-alphamonomer5-352
100.0CL;SO4;LPZ;
Fragment RZ132 in complex with MAP kinase p38-alphamonomer5-352
100.0LO8;CL;MG;SO4;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13838a in complex with MAP…monomer5-352
100SQM;CL;MG;SO4;GOL;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11302a in complex with MAP…monomer5-352
100SVJ;CL;MG;SO4;DMS;
Fragment N11290a in complex with MAP kinase p38-alphamonomer5-352
100.0LOQ;CL;MG;SO4;EDO;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N09036b in complex with MAP…monomer5-352
100SV4;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13619a in complex with MAP…monomer5-352
100.0SU7;CL;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N10836b in complex with MAP…monomer5-352
100.0SVD;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11337a in complex with MAP…monomer5-352
100SVG;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N06122b in complex with MAP…monomer5-352
10054F;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N08141b in complex with MAP…monomer5-352
100PO6;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N07422b in complex with MAP…monomer5-352
100.0LVD;CL;SO4;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N01381c in complex with MAP…monomer5-352
100SN4;CL;MG;SO4;ACT;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13866a in complex with MAP…monomer5-352
100.0JGM;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13502a in complex with MAP…monomer5-352
100AYS;CL;MG;SO4;DMS;
Fragment N13569a in complex with MAP kinase p38-alphamonomer5-352
100.0LO5;CL;MG;SO4;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13475a in complex with MAP…monomer5-352
100.0JMM;CL;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N08051b in complex with MAP…monomer5-352
100SWD;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14109a in complex with MAP…monomer5-352
100SQG;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment S00888c in complex with MAP…monomer5-352
100.0N9J;CL;MG;SO4;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13470a in complex with MAP…monomer5-352
100A9B;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13430a in complex with MAP…monomer5-352
100SFY;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13611a in complex with MAP…monomer5-352
100.0NZ4;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11396a in complex with MAP…monomer5-352
100SLY;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment PC587 in complex with MAP k…monomer5-352
100RGY;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL057 in complex with MAP …monomer5-352
100.0SNV;CL;MG;SO4;DMS;ACT;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14074a in complex with MAP…monomer5-352
100.07ZC;CL;MG;SO4;ACT;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13413a in complex with MAP…monomer5-352
100K3D;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL095 in complex with MAP …monomer5-352
100.0SQ7;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13693a in complex with MAP…monomer5-352
100.0S7S;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N05711b in complex with MAP…monomer5-352
100.02O6;CL;MG;SO4;DMS;
Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717monomer5-352
100.0SO4;LIE;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13477a in complex with MAP…monomer5-352
100.06T5;CL;MG;SO4;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13418a in complex with MAP…monomer5-352
100.0A7K;CL;MG;SO4;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment TCJ795 in complex with MAP …monomer5-352
100.0SQY;CL;SO4;DMS;EDO;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11338a in complex with MAP…monomer5-352
100SVM;CL;SO4;DMS;
Fragment N14056a in complex with MAP kinase p38-alphamonomer5-352
100.0LOE;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13598a in complex with MAP…monomer5-352
100STV;CL;MG;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13619a in complex with MAP…monomer5-352
100.0SU7;CL;MG;SO4;DMS;EDO;
Mutated Mouse P38 MAP Kinase Domain in complex with Inhibitor PG-892579monomer5-352
100.0LID;
p38 inhibitor-boundmonomer5-352
100.0P7B;BOG;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13421a in complex with MAP…monomer5-352
100.0JFS;CL;SO4;DMS;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11351a in complex with MAP…monomer5-352
100SW7;CL;MG;SO4;DMS;
Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone In…monomer5-352
99.7LI9;
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13724a in complex with MAP…monomer5-352
100.0SQP;CL;MG;SO4;DMS;
P38 inhibitor-boundmonomer5-352
100.0BOG;P5K;
Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743monomer5-352
100.0LIB;
P38 inhibitor-boundmonomer5-352
100.0BOG;P79;
p38 inhibitor-boundmonomer5-352
100.0BOG;P7C;
P38 inhibitor-boundmonomer5-352
100.0BOG;P78;
p38 inhibitor-boundmonomer5-352
100.0BOG;P7A;
Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449monomer5-352
100.0LIC;
Crystal structure of p38 complex with 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(6-morpholin-…monomer5-352
99.39G2G;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6y4x.1.Amonomer0.831-360
O8Q;100.00